A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 38/19 (2006.01) A61P 43/00 (2006.01)
Patent
CA 2749802
Disclosed are compositions and methods for treating, preventing and ameliorating conditions and diseases characterized by a lowered white blood cell count. The methods and compositions described herein include a fusion polypeptide formed from human serum albumin protein ("HSA") and human granulocyte- colony stimulating factor ("G-CSF").
La présente invention concerne des compositions et des méthodes de traitement prophylactique et thérapeutique et de soulagement d'états pathologiques et de maladies caractérisés par une diminution de la numération des leucocytes. Les méthodes et compositions décrites dans la présente invention incluent un polypeptide de fusion formé à partir de protéine d'albumine sérique humaine (« HSA ») et de facteur de stimulation de colonie de granulocytes humains (« G-CSF »).
Bell Adam Carr
Bock Jason Benjamin
Herpst Jeffrey
Goudreau Gage Dubuc
Teva Pharmaceutical Industries Ltd.
LandOfFree
Recombinant human albumin-human granulocyte colony... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant human albumin-human granulocyte colony..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant human albumin-human granulocyte colony... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1846707